Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.
Huston
Alissa
A
Brown
Jason
J
Roodman
G David
GD
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D003907:Dexamethasone / Q000009:adverse effects* / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood; D007146:Immunoglobulin lambda-Chains / Q000097:blood / Q000652:urine; D008297:Male; D009101:Multiple Myeloma / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D051437:Renal Insufficiency / Q000209:etiology; D013792:Thalidomide / Q000009:adverse effects* / Q000627:therapeutic use; D016896:Treatment Outcome; D015275:Tumor Lysis Syndrome / Q000209:etiology*
D007070:Immunoglobulin A; D007146:Immunoglobulin lambda-Chains; D013792:Thalidomide; D003907:Dexamethasone